SURVIVAL ANALYSIS OF PATIENTS WITH CLASSICAL HODGKIN´S LYMPHOMA TREATED WITH ABVD: RESULTS FROM TWO REFERRAL CENTERS IN MEXICO CITY.
EHA Library, Erick Crespo-Solís, 182580
OUTCOME OF PD-1 BLOCKADE IN PATIENTS WITH RELAPSED HODGKIN LYMPHOMA AND ACTIVE GRAFT-VERSUS-HOST DISEASE
EHA Library, Adrian Minson, 182581
PROGNOSTIC VALUE OF THE RED CELL DISTRIBUTION WIDTH IN PATIENTS WITH CLASSIC HODGKIN LYMPHOMA
EHA Library, Vlatka Periša, 182582
HIGH FREQUENCY OF SECONDARY MALIGNANCIES (SM) IN PATIENTS WITH LARGE GRANULAR LYMPHOCYTIC LEUKEMIA (LGLL): A SINGLE INSTITUTIONAL EXPERIENCE.
EHA Library, Leidy Isenalumhe, 182583
BENDAMUSTINE AND RITUXIMAB COMBINATION THERAPY WITH SUBSEQUENT RITUXIMAB SUPPORTING THERAPY IN RUSSIAN SUBJECTS WITH RELAPSED OR REFRACTORY INDOLENT B-CELL NON-HODGKIN LYMPHOMAS
EHA Library, Irina PODDUBNAYA, 182584
PROGNOSTIC VALUE OF G8 SCREENING TOOL IN PATIENTS WITH INDOLENT B-CELL LYMPHOPROLIFERATIVE NEOPLASMS - A SINGLE CENTRE EXPERIENCE
EHA Library, Zorica Cvetkovic, 182585
A PROSPECTIVE PHASE 2 TRIAL EVALUATING MONOTHERAPY WITH OFATUMUMAB FOR RELAPSED/REFRACTORY SPLENIC B-CELL MARGINAL ZONE LYMPHOMA (MORE TRIAL): SAFETY ANALYSIS RESULTS
EHA Library, Lydia Scarfò, 182586
TREATMENT PATTERNS AND TREATMENT RESPONSE IN PATIENTS WITH FOLLICULAR LYMPHOMA (FL) IN ROUTINE CLINICAL CARE - A UNITED STATES (US) ELECTRONIC MEDICAL RECORD (EMR) DATABASE STUDY
EHA Library, Augustina Ogbonnaya, 182587
PET-CT AND BONE MARROW BIOPSY IN STAGING FOLICULAR LYMPHOMA IN A SINGLE INSTITUTION
EHA Library, Ivonne Parraga, 182588
SURVIVAL OUTCOMES AFTER FIRST-LINE THERAPY IN FOLLICULAR LYMPHOMA (FL) USING A UNITED STATES (US) ELECTRONIC MEDICAL RECORD (EMR)-BASED COHORT
EHA Library, Augustina Ogbonnaya, 182589
RITUXIMAB MAINTENANCE AFTER R.BENDAMUSTINE FOR PATIENTS WITH UNTREATED FOLLICULAR LYMPHOMA : A REAL LIFE STUDY IN SOUTHERN ITALY ON BEHALF OF RETE EMATOLOGICA PUGLIESE
EHA Library, GIUSEPPE TARANTINI, 182591
ROLE OF F-18 FDG-PET/CT IN DETECTING LYMPHOMATOUS BONE MARROW INVOLVEMENT IN THE INITIAL STAGING OF PATIENTS WITH LYMPHOMA
EHA Library, Belén Hernandez Ruiz, 182593
PREDICTIVE FACTORS FOR INFECTIOUS ADVERSE EVENTS IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA TREATED WITH BENDAMUSTINE-RITUXIMAB (R) ± R MAINTENANCE. RESULTS OF A RETROSPECTIVE ANALYSIS.
EHA Library, Alice Di ROCCO, 182594
CAUSES OF DEATH OF FOLLICULAR LYMPHOMAS. MONOCENTRIC AND RETROSPECTIVE STUDY WITH A LONG PERIOD OF OBSERVATION.
EHA Library, Luigi Rigacci, 182595
CLINICAL CHARACTARISTICS AND PROGNOSIS OF PATIENTS WITH INDOLENT NON-HODGKIN LYMPHOMA AND RISK OF TRANSFORMATION TO AGGRESSIVE LYMPHOMA: A SINGLE JORDANIAN CENTER EXPERIENCE
EHA Library, Deeb Zahran, 182596
OCULAR ADNEXAL LOW GRADE LYMPHOMA TREATMENT OUTCOMES AND LONG TERM FOLLOW UP: A SINGLE CENTRE EXPERIENCE
EHA Library, Nagah Elmusharaf, 182597
AGE AS A POTENTIAL NOVEL PROGNOSTIC INDICATOR IN PRIMARY CUTANEOUS B-CELL LYMPHOMA.
EHA Library, Poorvi Desai, 182598
EPIDEMIOLOGY, CHARACTERIZATION AND THERAPEUTIC MANAGEMENT OF MARGINAL ZONE LYMPHOMA: A SINGLE-CENTER EXPERIENCE
EHA Library, Carlos de Miguel Jiménez, 182599
HAIRY CELL LEUKEMIA AND B-RAF MUTATIONS
EHA Library, Aybüke Olgun, 182600
BENDAMUSTINE-RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA PREVIOUSLY EXPOSED TO RITUXIMAB. EXPERIENCE IN SEVEN HOSPITALS OF THE SPANISH GELTAMO GROUP
EHA Library, Juan Alfonso Soler Campos, 182601
USE OF RADIATION THERAPY FOR THE TREATMENT OF GASTRIC MALT LYMPHOMA
EHA Library, Esther , 182602
USE OF LIPEGFILGRASTIM IN CLINICAL PRACTICE FOR THE PROPHYLAXIS OF CHEMOTHERAPY-INDUCED NEUTROPENIA IN LYMPHOMA PATIENTS: INTERIM RESULTS OF A PAN-EUROPEAN NON-INTERVENTIONAL STUDY
EHA Library, Elizabeth Treacy, 182603
TUBERCULOSIS IN ACUTE LEUKEMIA- AN ANALYSIS OF CLINICAL CHARACTERISTICS AND IMPACT ON MANAGEMENT IN 25 PATIENTS
EHA Library, Charanpreet Singh, 182604
INCIDENCE OF BACTEREMIA BY MULTI-RESISTANT BACTERIA IN HEMATOLOGY PATIENTS. A DESCRIPTIVE EPIDEMIOLOGIC STUDY FROM A THIRD LEVEL HOSPITAL.
EHA Library, Agustin Nieto Vazquez, 182605
INFECTIONS PRESENTING IN THE BONE MARROW IN HIV POSITIVE PATIENTS AND THEIR MORPHOLOGICAL ASSOCIATIONS - SIX YEAR DATA FROM AN INDIAN TERTIARY CARE HOSPITAL
EHA Library, Richa Gupta, 182606
UTILITY OF BONE MARROW BIOPSY IN FEVER OF UNKNOWN ORIGEN: A CRITICAL ANALYSIS OF A RETROSPECTIVE SERIE.
EHA Library, Harberth Fernandez - Leyva, 182607
THE OUTCOME OF PEDIATRIC CANCER PATIENTS ADMITTED TO THE INTENSIVE CARE UNIT OF A TERTIARY HOSPITAL IN GWANGJU-CHONNAM, KOREA
EHA Library, Hoon Kook, 182608
EFFICACY AND SAFETY OF TIGECYCLINE IN FEBRILE NEUTROPENIC PATIENTS WITH HEMATOLOGIC MALIGNANCIES AND CARBAPENEM RESISTANCE: A MULTICENTRE RETROSPECTIVE STUDY FROM CHINESE PEOPLE
EHA Library, Bing Xu, 182609
BONE MARROW CYTOLOGICAL CHARACTERIZATION OF PATIENTS WITH HIPERREACTIVE MALARIAL SPLENOMEGALY
EHA Library, Elvira de la Vega, 182610
ACUTE APPENDICITIS IN LEUKEMIA PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE NEUTROPENIC PHASE
EHA Library, Qiuxia Zhang, 182611
EPIDEMIOLOGY OF BLOODSTREAM INFECTIONS IN NEUTROPENIC AND NON-NEUTROPENIC PATIENTS WITH MALIGNANCY
EHA Library, Nadeem Raja, 182612
CHANGING TREND IN LOCAL BACTERIAL EPIDEMIOLOGY :EXPERIENCE IN ACUTE LEUKEMIA PATIENTS HOSPITALIZED IN SINGLE HEMATOLOGY UNIT
EHA Library, Caterina BUQUICCHIO, 182613
UK SINGLE-CENTRE SERVICE EVALUATION TO DESCRIBE THE IMPACT ON HEALTHCARE RESOURCE USE OF LOCAL ANTIFUNGAL PROPHYLAXIS AND TREATMENT PROTOCOLS IN THE MANAGEMENT OF HIGH-RISK PATIENTS WITH NEUTROPENIA
EHA Library, Georgie Nock, 182614
REAL-LIFE FEASIBILITY OF AN IRON CHELATION PROGRAM WITH DEFERASIROX IN MYELODYSPLASIA AND OTHER ACQUIRED CHRONIC ANEMIAS: A SINGLE CENTRE EXPERIENCE
EHA Library, Giambattista BERTANI, 182615
NONINVASIVE TRANSCUTANEOUS SPOT-CHECKING OF TOTAL HEMOGLOBIN (SPHB) FOR THE SCREENING OF ANEMIA IN CAMBODIAN CHILDREN FROM REMOTE RURAL AREAS.
EHA Library, Jaime PEREZ DE OTEYZA, 182616
IRON DEFICIENCY ANEMIA IN INFANTS AND YOUNG CHILDREN
EHA Library, Sangkyu Park, 182617
THE ROLE OF ZINC PROTOPORPHYRIN IN THE DIAGNOSIS OF SIDEROPENIC ANEMIA
EHA Library, Telma Nascimento, 182618
HYPERFERRITINEMIA AND SERUM INFLAMMATORY CYTOKINES IN 71 ADULTS WITH NEWLY DIAGNOSED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY
EHA Library, Maciej Machaczka, 182619
REDUCING UNNECESSARY BLOOD FILMS USING AN IRON DEFICIENCY ALGORITHM
EHA Library, Rebecca O'Toole, 182620
THE RELATIONSHIP ENDOTHELIAL MICROPARTICLES AND ASYMMETRIC DIMETIL ARGININE IN CHILDREN WITH IRON DEFICIENCY AND IRON DEFICIENCY ANEMIA
EHA Library, Yasemin ALTUNER TORUN, 182621
INVESTIGATION OF IRON METABOLISM FOR REGULATING MEGAKARYOPOIESIS AND PLATELET COUNT ACCORDING TO THE MECHANISMS OF ANEMIA
EHA Library, Sun Young Cho, 182622
SOLUBLE TRANSFERRIN RECEPTOR LEVELS OF APPARENTLY HEALTH ADULTS IN PORT HARCOURT NIGERIA
EHA Library, Chilota Efobi, 182623
ROLE OF PRO-PHAGOCYTIC CALRETICULIN AND ANTI-PHAGOCYTIC CD47 IN MDS AND MPN MODELS TREATED WITH AZACYTIDINE OR RUXOLITINIB
EHA Library, Kristian BOASMAN, 182624
GENETIC VARIANTS OF MSH3 AND BLM GENES MAY INFLUENCE MYELODYSPLASTIC SYNDROME SUSCEPTIBILITY AND PROGNOSIS
EHA Library, Ana Bela Sarmento-Ribeiro, 182625
LOW RPS14 EXPRESSION IN MDS PATIENTS WITHOUT 5Q- ABERRATION SEEMS NOT TO BE RELATED WITH GENOMIC ALTERATIONS IN 5Q REGION
EHA Library, Maria Linares, 182626
INTEREST OF THE XN-10® ANALYZER TO SCREEN FOR MYELODYSPLASTIC SYNDROMES ON COMPLETE BLOOD COUNTS (CBC)
EHA Library, Marion Eveillard, 182627
PROGRESSION SCORE FOR ACUTE LEUKEMIA - A NEW PROGNOSTIC SCORE IN MDS?
EHA Library, Emília Cortesão, 182628
CORRELATION OF PATIENT PROGNOSIS WITH PU.1 AND JDP2 PROVIDES POTENTIAL NOVEL PROGNOSTIC/DIAGNOSTIC MARKERS IN MDS.
EHA Library, Rachael Simpson, 182629
DECREASED EXPRESSION OF DECORIN, A WNT-PATHWAY RELATED PROTEIN, IN MESENCHYMAL STEM CELLS OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES
EHA Library, KONSTANTIA PAVLAKI, 182630
CLINICAL FEATURES, CYTOGENETIC STUDY AND OUTCOME OF ADULT MYELODYSPLASTIC SYNDROMES: REVIEW OF 101 CASES, A SINGLE CENTER EXPERIENCE IN ALGERIA.
EHA Library, Souad Taoussi, 182631
CLINICAL EVOLUTION OF ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
EHA Library, Gustavo Alberto PINTO SOLANO, 182632
SAFETY, EFFICACY, AND PHARMACOKINETICS OF INTRAVENOUS RIGOSERTIB IN JAPANESE PATIENTS WITH RECURRENT/RELAPSED OR REFRACTORY MYELODYSPLASTIC SYNDROMES (MDS): A MULTICENTER, OPEN-LABEL, PHASE I STUDY
EHA Library, Michinori Ogura, 182633
IRON CHELATION THERAPY IMPROVES HAEMATOLOGICAL RESPONSE IN HIGH-RISK MYELODYSPLASTIC PATIENTS TREATED WITH AZACITIDINE
EHA Library, Salvatore Improta, 182634
EXPLORING THE RISK OF RED CELL ALLOIMMUNIZATION IN MYELODYSPLASTIC SYNDROMES. TO WHAT EXTEND COULD CYTOGENETIC ANALYSIS AT DIAGNOSIS PREDICT THIS RISK?
EHA Library, Ioannis , 182635
PROGNOSTIC MARKERS THAT PREDICT THE OUTCOME OF REDUCED INTENSITY CONDITIONING TRANSPLANT IN ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A SINGLE CENTER EXPERIENCE
EHA Library, Shaimaa El-Ashwah, 182636
MANAGEMENT OF MYELODYSPLASTIC SYNDROMES WITH ERYTHROPOIESIS STIMULATING AGENTS (ESAS) IN REAL-LIFE EXPERIENCE: AN UPDATE FROM RECAMDS
EHA Library, Claudio Cerchione, 182637
CHARACTERIZATION OF MYELODYSPLASTIC SYNDROMES WITH TRANSFORMATION TO ACUTE LYMPHOBLASTIC LEUKAEMIA
EHA Library, Sabine Blum, 182638
IMMUNOSUPPRESSIVE THERAPY AS FIRST-LINE TREATMENT OF PATIENTS WITH PRIMARY MDS
EHA Library, Natallia Klimkovich, 182639
VITAMIN D IS ASSOCIATED WITH SEVERITY OF DISEASE AS EXPRESSED BY SUBDIAGNOSIS AND IPSS-R IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND RELATED DISEASES
EHA Library, Catharina Müller-Thomas, 182640
JUVENILE MYELOMONOCYTIC LEUKEMIA IN TURKEY: A RETROSPECTIVE ANALYSIS OF 65 PATIENTS
EHA Library, Ozlem Tufekci, 182641
THE PRECURSOR B CELLS AS A PROGNOSIS FACTOR IN MYELODYSPLASTIC SYNDROMES
EHA Library, Gustavo Alberto PINTO SOLANO, 182642
TO INFINITY AND BEYOND: NGS IN MDS
EHA Library, André Barbosa Ribeiro, 182643
CLINICAL FEATURES, CYTOGENETIC STUDY AND OUTCOME OF ADULT MYELODYSPLASTIC SYNDROMES: REVIEW OF 101 CASES, A SINGLE CENTER EXPERIENCE IN ALGERIA.
EHA Library, Souad Taoussi, 182644
IS PRE-TRANSPLANT THERAPY A KEY FACTOR IN INFLUENCING POST TRANSPLANTATION RELAPSE INCIDENCE IN EXCESS BLAST (EB) MYELODYSPLASTIC SYNDROMES? A SINGLE CENTRE EXPERIENCE
EHA Library, Giambattista BERTANI, 182645
IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROMES AND IN OTHER TRANSFUSION-DEPENDENT CHRONIC ANEMIAS. RETROSPECTIVE STUDY OF 69 PATIENTS FROM A SINGLE INSTITUTION
EHA Library, Carlo Finelli, 182646
VCAM-1 AS A NOVEL DRUG THERAPY TARGET OF BONE MARROW MESENCHYMAL STEM CELLS IN MULTIPLE MYELOMA
EHA Library, Alejandra Ortiz-Ruiz, 182647
RALA AND RALB MEDIATE CELL SURVIVAL INDEPENDENTLY OF ONCOGENIC RAS AND PROVIDE POTENTIAL THERAPEUTIC TARGETS IN MULTIPLE MYELOMA
EHA Library, Marcel Seibold, 182648
CXCR4 MUTATIONS FOUND BY USING DEEP SEQUENCING WITHOUT SORTING B CELLS, AND PROGNOSTIC IMPLICATION IN WALDENSTROM MACROBULINEMIA
EHA Library, Sung Min KIM, 182649
THE CLINICAL IMPACT OF CHROMOSOMAL TRANSLOCATION T(14;16)(Q32;Q23) IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Lenka Pavlistova, 182650
THE ROLE OF NEUROTROPHINS AND ANGIOGENIC CYTOKINES IN THE PATHOPHYSIOLOGY OF PERIPHERAL NEUROPATHY IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Karolina Łuczkowska, 182651
INFLUENCE OF XRCC5, XRCC4, NFKB2, AND BIRC5 GENES POLYMORPHISMS IN THE RISK AND PROGNOSIS OF MONOCLONAL GAMMOPATHIES
EHA Library, Ana Bela Sarmento-Ribeiro, 182652
SILENCE OF LONG NONCODING RNA MALAT1 BY RNA INTERFERENCE INHIBITS PROLIFERATION AND INDUCES APOPTOSIS IN MULTIPLE MYELOMA
EHA Library, Zuofei Chi, 182653
LONG NON-CODING RNA MEG3 FUNCTIONS AS A COMPETING ENDOGENOUS RNA TO REGULATE PTEN EXPRESSION BY SPONGING MIR-181A IN MULTIPLE MYELOMA
EHA Library, Lijuan Chen, 182654
IMPROVE RISK-STRATIFICATION OF MULTIPLE MYELOMA PATIENT WITH MICROFLUIDIC DEVICES
EHA Library, John Zhong, 182655
SERUM FREE LIGHT CHAIN RATIO IS AN INDEPENDENT RISK FACTOR FOR PROGRESSION IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
EHA Library, Cherif Rahali, 182656
INTENSITY OF EXPRESSION OF MULTIDRUG RESISTANCE GENES AFFECT ON THE OVERALL SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA WERE TREATED WITH BORTEZOMIB AND ASSOCIATED WITH THE INITIAL MULTIDRUG RESISTANCE
EHA Library, Yulia Chernykh, 182657
ASSOCIATIONS OF IL-1, IL-4 AND TGF-Β1 POLYMORPHISMS WITH CYTOGENETIC PROFILES IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Anastasia Pavlova, 182658
CORRELATION DEPENDENCE OF CHRONIC LYMPHOPROLIFERATIVE DISORDERS, MULTIPLE MYELOMA FROM CHANGES OF IMMUNE RESPONSE GENES PROFILE
EHA Library, Elena Nazarova, 182659
FEATURES OF STROMAL ELEMENTS OF HEMATOPOIETIC BONE MARROW NICHE IN MULTIPLE MYELOMA
EHA Library, Natalya Semenova, 182660
IMPACT OF RENAL IMPAIRMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA IN A REAL WORLD SETTING.
EHA Library, Virginia Bove, 182663
THE EXPRESSION OF THE TRYPTASE POSITIVE MAST CELLS AND THE LEVELS OF IL-17, CORRELATE WITH ANGIOGENIC FACTORS IN PATIENTS WITH MULTIPLE MYELOMA
EHA Library, Rodanthi Vyzoukaki, 182664
HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH DIFFERENT TREATMENT MODALITIES OF RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN THE US: FINDINGS FROM PREAMBLE
EHA Library, Clara Chen, 182665
ASSOCIATION OF SERUM HEAVY/LIGHT CHAIN PAIR SUPPRESSION WITH RISK FACTORS FOR PROGRESSION IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND SMOLDERING MYELOMA
EHA Library, Ignacio Isola, 182666
EXTRAMEDULLARY MYELOMA IN THE “NOVEL AGENTS ERA”: OUTCOME, HETEROGENEITIES AND PECULIARITIES OF A COHORT OF 84 PATIENTS RETROSPECTIVELY ANALYSED IN A MONOCENTRIC EXPERIENCE
EHA Library, Lorenza Torti, 182667
DINAMIC PREDICTIVE FACTORS FOR A BETTER STRATIFICATION OF PATIENTS WITH R-ISS II NEWLY DIAGNOSED MULTIPLE MYELOMA (MM)
EHA Library, Massimo Offidani, 182668
THE IMPACT OF THE UPDATED IMWG DIAGNOSTIC CRITERIA IN A REAL-LIFE SMM COHORT : A SINGLE CENTER EXPERIENCE
EHA Library, Philip Vlummens, 182669
RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN 401 MULTIPLE MYELOMA PATIENTS: OBSERVATION OVER A 25-YEARS PERIOD IN A SINGLE INSTITUTION.
EHA Library, Mariana Fernandez Caballero, 182670
A PHASE III RANDOMIZED, OPEN-LABEL STUDY OF ISATUXIMAB (SAR650984) PLUS POMALIDOMIDE (POM) AND DEXAMETHASONE (DEX) VERSUS POM AND DEX IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, PAUL RICHARDSON, 182671
LONG TERM SURVIVAL OF IGM MULTIPLE MYELOMA AND WALDENSTRŐM’S MACROGLOBULINEMIA PATIENTS
EHA Library, Maria Kraj, 182672
MULTISITE PERFORMANCE EVALUATION STUDY OF THE BD ONEFLOW PLASMA CELL DISORDERS (PCD) PANEL
EHA Library, Balaji Balasa, 182673
PRACTICE GAPS AND BARRIERS TO OPTIMAL MANAGEMENT OF MULTIPLE MYELOMA PATIENTS : RESULTS FROM A MIXED-METHODS STUDY IN 8 EUROPEAN COUNTRIES.
EHA Library, Mohamad Mohty, 182674
THE EXPRESSION OF APRIL BY MULTIPLE MYELOMA CELLS AND THEIR ROLE IN THE EVOLUTION OF MULTIPLE MYELOMA
EHA Library, Peggy Kanellou, 182675
DEVELOPMENT OF SECOND PRIMARY MALIGNANCY AFTER TREATMENT WITH LENALIDOMIDE: A SINGLE CENTRE EXPERIENCE.
EHA Library, Fergal McGlynn, 182676
SOLITARY PLASMACYTOMA. A SINGLE-CENTRE RETROSPECTIVE STUDY.
EHA Library, Kyra Velazquez Kennedy, 182677
RISK STRATIFICATION ALGORITHM USING REAL-WORLD DATA FROM PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): DESCRIPTION OF CLINICAL OUTCOME BY TREATMENT REGIMEN
EHA Library, Roman Hájek, 182678
LACK OF CD56 EXPRESSION IN MULTIPLE MYELOMA PATIENTS WITH RISS 2 DISEASE IS ASSOCIATED WITH WORSE PROGNOSIS AND ABOLISHED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION
EHA Library, Matevz Skerget, 182679
AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE MYELOMA IN GERMANY -REAL-WORLD DATA FROM A NATIONWIDE, MULTI-INSTITUTIONAL SURVEY IN 2015-2016
EHA Library, Maximilian Merz, 182680
MODIFIED HYPERCVAD VERSUS BORTEZOMIB-HYPERCVAD IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
EHA Library, Emma Scott, 182681
EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/ REFRACTORY MULTIPLE MYELOMA: A REAL LIFE EXPERIENCE FROM TURKEY
EHA Library, Guray Saydam, 182682
OPTIMIZING THE MANAGEMENT OF NON-HEMATOLOGICAL ADVERSE EFFECTS RELATED TO LENALIDOMIDE IN RELAPSED MULTIPLE MYELOMA PATIENTS. ONE CENTER EXPERIENCE.
EHA Library, María , 182683

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings